RxDoctor Payments Data

Allan Luskin, MD

Allergy & Immunology · Madison, WINPI 1902855174

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $41,856 of the $50,956 with a category attached, or 82.1%. Genentech USA, Inc. accounts for 92.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $42,342 and has fallen 92.1% since, to $3,340 in 2021. Among allergy & immunology clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$50,956in general payments, 2019–2025

Across 42 payments — averaging $1213.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$47K
  • F. Hoffmann-la Roche AG$3K
  • AstraZeneca$550
  • Alk-abello, Inc$123
  • Sanofi-aventis U.S. LLC$25
$2,286in research payments, 2019–2025

Across 1 payment — averaging $2285.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$2K

What the payments were for

  • Speaking & faculty fees$41,85682%
  • Travel & lodging$7,92416%
  • Food & beverage$1,1772%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$50,956 in reported general payments places this provider in the 90th percentile of 55 allergy & immunology providers in Wisconsin.

See all allergy & immunology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$484,920
Medicare patients
135
Services billed
14,513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab25$115,396
Dupixent PenDupilumab16$59,993
XolairOmalizumab12$31,791
Breo ElliptaFluticasone/Vilanterol34$22,662
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$17,694
Arnuity ElliptaFluticasone Furoate22$9,779
DuleraMometasone/Formoterol18$8,940
Advair HfaFluticasone Propion/Salmeterol17$8,200
Incruse ElliptaUmeclidinium Bromide20$7,385
Fluticasone-SalmeterolFluticasone Propion/Salmeterol28$6,241
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate13$3,250
Epinephrine12$3,154
Wixela InhubFluticasone Propion/Salmeterol12$2,474
Ventolin HfaAlbuterol Sulfate30$1,815
Montelukast Sodium88$1,293

Paid to pharmacies, not to this prescriber.

Other allergy & immunology in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →